Skip to content
Carbohydrate-restricted13 human studies cited

Ketogenic

Written by Reviewed Sep 2026

Also called: Keto, Very low carbohydrate, LCHF

At fixed calories the metabolic advantage is worth tens of kilocalories a day, and a pooled analysis of 32 controlled feeding studies found it running the other way. When people eat freely it often works, and the mechanism is appetite.

What it actually is

Carbohydrate low enough to produce measurable ketosis, generally under about 50 g a day, verified by blood beta-hydroxybutyrate. That verification is the whole problem with the literature, because most trials labelled low carbohydrate never measured a ketone. In DIETFITS the arm called healthy low carbohydrate reached 30 percent of energy from carbohydrate at twelve months, which is not ketogenic. POUNDS LOST, cited constantly in this debate, had a lowest arm at 35 percent of energy, which is not even low carbohydrate. Before accepting that a study shows keto works, check which of the two things it studied.

The mechanism its advocates propose

The carbohydrate-insulin model holds that dietary carbohydrate raises insulin, insulin suppresses fat release from adipose tissue, and the trapped energy drives both hunger and fat storage. Restrict carbohydrate and the argument is that fat becomes available, energy expenditure rises, and weight is lost for reasons independent of calories. This is a coherent, testable hypothesis, which is why it has been tested in metabolic wards, and stating it fairly is the fair way to test it.

What happened when calories were controlled

Strongest design available: controlled

Energy intake was matched between groups, so a difference in the result is attributable to the composition of the diet rather than to how much was eaten.

The advantage is real, tiny, and in the best pooled analysis it points the other way. Nothing here supports the claim that ketosis itself produces meaningful fat loss at matched intake.

  • Hall 2015, NIH metabolic ward, 19 adults with obesity, isocaloric, both diets in every subject. Carbohydrate restriction produced 53 g/day of body fat loss. Fat restriction produced 89 g/day, significantly more (p = 0.002).
  • Hall and Guo 2017 pooled 32 controlled feeding studies swapping carbohydrate for fat at equal calories. Both energy expenditure (26 kcal/day) and fat loss (16 g/day) were greater on the lower fat diets. That is the opposite of the metabolic advantage claim, and the magnitude is trivial in both directions.
  • Hall 2016, 17 men, four weeks isocaloric ketogenic with protein clamped. Energy expenditure rose 57 kcal/day in the chamber and 151 kcal/day by doubly labelled water. In the same paper, body fat loss slowed and fat free mass was lost. Both sides cite this trial and both halves are in it.
  • Johnston 2006 is the cleanest test of ketosis itself: 20 adults, six weeks, intake strictly controlled, ketogenic versus non-ketogenic at the same low carbohydrate. Weight loss 6.3 versus 7.2 kg (p = 0.324) and fat loss 3.4 versus 5.5 kg (p = 0.111). Both point estimates favoured the non-ketogenic arm. The authors concluded that ketogenic diets for weight loss are not warranted.
  • Noakes 2006, 83 participants on three isocaloric diets. Fat mass loss did not differ. Lean mass was 32 percent of total loss on very low carbohydrate against 21 percent on high unsaturated fat, so the arm claimed to spare lean tissue did not.
  • Vargas 2018, 24 trained men in a calorie surplus with resistance training. The non-ketogenic arm gained 1.3 kg of muscle. The ketogenic arm gained nothing. Arms of 9 and 10, so read it as a signal rather than a settled finding.

What happened when people just ate it

This is where the pattern earns its reputation, and the mechanism is appetite rather than metabolism. In free-living trials it frequently wins at six months and the advantage shrinks or vanishes by one to two years. Foster 2003 found a large six-month gap that came to nothing at twelve months (minus 4.4 versus minus 2.5 percent, p = 0.26), with the authors noting that adherence was poor and attrition high in both arms. Foster 2010, over two years with behavioural support in both arms, found about 11 kg lost at one year and 7 kg at two with no difference between groups in weight, body composition or bone density at any point. A TO Z did favour Atkins at twelve months, minus 4.7 kg against minus 1.6 to minus 2.6 kg. Bazzano 2014 favoured low carbohydrate by 3.5 kg at twelve months. DIETFITS, from the same investigator as A TO Z eleven years later, larger and with better diet quality in both arms, found a difference of 0.7 kg that was not significant. Then Hall 2021, admitting 20 adults to a ward and letting them eat freely, found the low fat diet led to 689 kcal/day less intake than the ketogenic one, which is the opposite of what the carbohydrate-insulin model predicts. The model's proponents argue two weeks is too short for the adaptations it posits. That disagreement is unresolved.

Protein, and whether it confounds the result

Protein is the confounder that explains a good part of this literature. Low carbohydrate diets in practice run higher in protein, and protein independently increases satiety and preserves lean mass, so a trial comparing low carbohydrate against low fat without matching protein is partly a protein trial. Johnston 2006 and Hall 2016 both clamped or controlled protein, which is exactly why they matter more than their sample sizes suggest, and both are null or negative for ketosis. Where protein was not matched, expect part of any advantage to belong to protein rather than to carbohydrate restriction.

The measured intakes behind the protein figures are on the protein page.

What reliably moves

MarkerDirectionFrom
TriglyceridesDown, reliably and substantiallyTay 2015, minus 0.73 mmol/L against minus 0.15 and minus 0.06 in comparator arms, p < 0.001. This is the most consistent biochemical effect of the pattern and it survives in every trial that measured it.
HDL cholesterolUpFoster 2010 found HDL higher on low carbohydrate at every time point, about 23 percent higher at two years.
LDL cholesterolUp in some people, sharply in a minorityNoakes 2006 found LDL up 7 percent on very low carbohydrate only (p < 0.001 against the other arms). Johnston 2006 found LDL directly correlated with blood beta-hydroxybutyrate (r = 0.297, p = 0.025), meaning the deeper the ketosis the higher the LDL. The hyper-responder phenomenon is real and this is the marker to watch.
Fasting insulinDownNoakes 2006, minus 33 percent on very low carbohydrate against minus 19 percent and no change (p < 0.001).
Glycaemic variability and medication needDown, and this is the strongest diabetes findingTay 2015 and 2018 were null on HbA1c and weight against an energy-matched high carbohydrate arm, but the low carbohydrate arm won on diabetes medication score (p = 0.02 and 0.03) and glycaemic variability (p = 0.003) at both one and two years. Needing less medication for the same HbA1c is a real benefit that the primary endpoint missed.
HomocysteineUpNoakes 2006 found a 6.6 percent rise on very low carbohydrate only (p = 0.026). Rarely mentioned.

Long term, and hard outcomes

Two years is the outer edge of good data, and by then the differences are mostly gone. Foster 2010 found no difference at two years. Tay 2018 found no difference at two years on weight, body fat, HbA1c, LDL, endothelial function or kidney measures, with only 61 of 115 participants completing. No trial of a ketogenic diet has ever measured a cardiovascular event, a fracture or a death as a primary endpoint. One genuinely reassuring long-term finding: a secondary analysis of the Tay trial measured fourteen micronutrients and iron markers at 0, 24, 52 and 104 weeks and found no differential response between arms, with everything staying in range. That was a professionally planned diet with partial food provision, so it says a well-designed ketogenic diet can be nutritionally replete for two years. It does not say a self-directed one is.

Citations

  1. Human2015
    Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity

    Cell Metabolism

    NIH metabolic ward, 19 adults, isocaloric, each subject on both diets. Carbohydrate restriction 53 g/day body fat loss against 89 g/day on fat restriction, p = 0.002.

  2. Human2016
    Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men

    American Journal of Clinical Nutrition

    17 men, four weeks isocaloric ketogenic with protein clamped. Energy expenditure rose 57 kcal/day in chamber and 151 by doubly labelled water, while body fat loss slowed and fat free mass was lost.

  3. Review2017
    Obesity energetics: body weight regulation and the effects of diet composition

    Gastroenterology

    32 controlled feeding studies swapping carbohydrate for fat at equal calories. Energy expenditure 26 kcal/day and fat loss 16 g/day both greater on lower fat diets, the opposite direction to the metabolic advantage claim.

  4. Human2006
    Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets

    American Journal of Clinical Nutrition

    20 adults, six weeks, intake strictly controlled, ketosis verified. Weight loss 6.3 against 7.2 kg (p = 0.324) and fat loss 3.4 against 5.5 kg (p = 0.111), both favouring the non-ketogenic arm. LDL correlated with blood beta-hydroxybutyrate.

  5. Human2006
    Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk

    Nutrition and Metabolism

    83 participants, three isocaloric diets. Fat mass loss did not differ. Lean mass was 32 percent of total loss on very low carbohydrate against 21 percent on high unsaturated fat. LDL up 7 percent and homocysteine up 6.6 percent on very low carbohydrate only.

  6. Human2018
    Effect of a high-fat ketogenic diet on body composition and strength in resistance-trained men

    Journal of the International Society of Sports Nutrition

    24 trained men, eight weeks of resistance training in a calorie surplus, urinary ketones measured weekly. Non-ketogenic arm gained 1.3 kg of muscle (p < 0.05); ketogenic arm gained none.

  7. Human2021
    Effect of a plant-based, low-fat diet versus an animal-based, ketogenic, low-carbohydrate diet on ad libitum energy intake

    Nature Medicine

    20 adults, inpatient, ad libitum crossover. The low fat diet led to 689 kcal/day less energy intake over two weeks (p < 0.0001), which is the opposite of the carbohydrate-insulin model's prediction.

  8. Human2018
    Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion (DIETFITS)

    JAMA

    The healthy low carbohydrate arm reached only 30 percent of energy from carbohydrate at twelve months, so this is not a ketogenic trial. Between-group difference 0.7 kg (95% CI minus 0.2 to 1.6), not significant.

  9. Human2010
    Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet

    Annals of Internal Medicine

    307 participants, two years, behavioural support in both arms, urinary ketones measured. About 11 kg lost at one year and 7 kg at two, with no between-group difference in weight, body composition or bone mineral density at any time point.

  10. Human2007
    Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women (A TO Z)

    JAMA

    311 free-living women, twelve months. Atkins minus 4.7 kg, Zone minus 1.6, LEARN minus 2.6, Ornish minus 2.2. Only Atkins versus Zone reached significance.

  11. Human2003
    A randomized trial of a low-carbohydrate diet for obesity

    New England Journal of Medicine

    63 adults, one year, minimal professional contact. A large six-month advantage narrowed to minus 4.4 against minus 2.5 percent of body weight at twelve months, p = 0.26. Adherence was poor and attrition high in both groups.

  12. Human2014
    Effects of low-carbohydrate and low-fat diets: a randomized trial

    Annals of Internal Medicine

    148 adults, twelve months. Favoured low carbohydrate: weight minus 3.5 kg (p = 0.002), fat mass minus 1.5 percent (p = 0.011), triglycerides and HDL both better. No clinical cardiovascular endpoints.

  13. Human2015
    Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial

    American Journal of Clinical Nutrition

    115 adults with type 2 diabetes, energy-matched diets with supervised exercise in both arms, 52 weeks. Null on weight and HbA1c. Low carbohydrate won on medication score, glycaemic variability, triglycerides and HDL.

  14. Human2018
    A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a 2-year trial

    Diabetes, Obesity and Metabolism

    The two-year continuation. Only 61 of 115 completed. Weight minus 6.8 against minus 6.6 kg, HbA1c minus 0.6 against minus 0.9, LDL and vascular measures all null. The medication and variability advantages persisted.

What people report

These are uncontrolled self-reports, not evidence. They are here because they tell you what to expect and what to watch for, which the trial literature does not. They cannot tell you whether anything works.

  • The first one to two weeks are widely described as difficult: headache, fatigue, poor exercise tolerance and irritability, commonly called keto flu and commonly attributed to sodium and fluid loss.
  • Strong appetite suppression is the most consistently reported effect, and it is the one the trial evidence actually supports as the mechanism.
  • Loss of high-intensity exercise capacity, reported often and consistent with reduced muscle glycogen. Endurance capacity is reported as preserved or improved.
  • Constipation, attributed to low fibre.
  • A large minority report an LDL rise on retest, and the community is genuinely split on whether it matters. This site takes no position on that dispute beyond noting that no trial has measured events on this diet.
  • Difficulty in social and travel settings is the most commonly cited reason for stopping.

Sources: Long-running discussion on r/keto and r/ketoscience, low carbohydrate practitioner write-ups, and the adherence commentary inside the trials themselves, notably Foster 2003 reporting poor adherence and high attrition in both arms. Uncontrolled self-report throughout. It tells you what to expect and proves nothing.

Who this is wrong for

  • Anyone with a familial lipid disorder, or anyone who has previously seen a large LDL rise on a high fat diet. The hyper-responder pattern is documented and the ketone-to-LDL correlation gives it a plausible route.
  • Anyone on a sodium-glucose cotransporter-2 inhibitor, where carbohydrate restriction raises the risk of euglycaemic ketoacidosis. This needs a prescriber, not a forum.
  • Anyone on insulin or a sulfonylurea without supervision, because the glucose-lowering effect is fast enough to cause hypoglycaemia within days. One participant in Hall 2021 withdrew for hypoglycaemia.
  • Anyone trying to gain muscle in a calorie surplus, on the strength of Vargas 2018, where the ketogenic arm gained none while the comparator gained 1.3 kg.
  • Anyone with a history of disordered eating, for whom a pattern built on eliminating a whole macronutrient and monitoring a blood marker daily is a poor structural fit.
  • Anyone with pancreatitis, a fat malabsorption condition, or a urea cycle disorder.

Questions

Does keto burn more fat than other diets at the same calories?
No. In a metabolic ward with intake fixed, carbohydrate restriction produced 53 g/day of fat loss against 89 g/day on fat restriction. A pooled analysis of 32 controlled feeding studies found both energy expenditure and fat loss slightly greater on lower fat diets. Whatever metabolic difference exists is measured in tens of kilocalories a day and does not favour keto.
So why does it work for so many people?
Appetite. In free-living conditions people on low carbohydrate diets often eat less without trying, and eating less is what produces the weight loss. That is a genuine and useful effect. It is just not the effect the marketing describes, and it means the diet works for the same reason every working diet works.
Is ketosis itself doing anything?
The one trial designed to test that compared ketogenic against non-ketogenic at the same low carbohydrate intake with calories controlled and ketones verified. Weight and fat loss both numerically favoured the non-ketogenic arm and neither difference was significant. With 20 participants the uncertainty is wide, and it is the most direct test anyone has run.
Will it raise my LDL?
In some people substantially. One trial found LDL up 7 percent on very low carbohydrate only, and another found LDL directly correlated with blood ketone level, meaning deeper ketosis tracked with higher LDL. Get a lipid panel before and about twelve weeks after starting. No trial on this diet has measured cardiovascular events, so nobody can tell you what your LDL change means for your risk.
Is it better for type 2 diabetes?
Not on HbA1c against an energy-matched comparator, in the best trial of this question, at either one or two years. It did consistently win on needing less diabetes medication for the same glucose control, and on glycaemic variability. Those are real advantages that the primary endpoint missed.